Severe Respiratory Syncytial Virus Pneumonia in a Kidney Transplant Recipient With Desensitization: Case Report and Comprehensive Review of the Literature

Exp Clin Transplant. 2020 Aug;18(4):515-518. doi: 10.6002/ect.2018.0252. Epub 2019 Apr 9.

Abstract

Herein, we report a rare case of severe respiratory syncytial virus pneumonia after kidney transplant in a 46-year-old woman. The patient was diagnosed with end-stage renal disease and underwent living-donor kidney transplant. Direct flow cytometry crossmatch testing yielded positive results, and desensitization treatment with rituximab, plasmapheresis, and im-munoglobulin was performed before transplant. There were no complications. Five days after discharge, the patient was readmitted with a 2-day history of fever and diagnosed with bilateral pneumonia. The patient was placed on mechanical ventilation and given renal replacement therapy. Respiratory syncytial virus in the bronchial washings was detected via polymerase chain reaction. Broad-spectrum antibiotics, intravenous methylprednisolone, and immunoglobulin were admin-istered. Over-immunosuppression strategies, such as desensitization therapy, may result in severe respiratory syncytial virus pneumonia, even in kidney transplant recipients.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Desensitization, Immunologic / adverse effects*
  • Female
  • Humans
  • Immunocompromised Host
  • Immunoglobulins, Intravenous / adverse effects
  • Immunosuppressive Agents / adverse effects
  • Kidney Failure, Chronic / surgery*
  • Kidney Transplantation / adverse effects*
  • Living Donors
  • Middle Aged
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / immunology
  • Opportunistic Infections / therapy
  • Opportunistic Infections / virology*
  • Plasmapheresis / adverse effects
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / therapy
  • Pneumonia, Viral / virology*
  • Respiratory Syncytial Virus Infections / diagnosis
  • Respiratory Syncytial Virus Infections / immunology
  • Respiratory Syncytial Virus Infections / therapy
  • Respiratory Syncytial Virus Infections / virology*
  • Respiratory Syncytial Virus, Human / immunology
  • Respiratory Syncytial Virus, Human / pathogenicity*
  • Rituximab / adverse effects
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Rituximab